The cost of Vowst can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Vowst. your treatment plan your ...
Hosted on MSN1mon
Seres Therapeutics receives $50 million from Nestlé Health ScienceThis payment is part of the transition obligations following the sale of Seres' VOWST business to Nestlé Health Science in September 2024. According to InvestingPro data, the company has been ...
Swiss food giant Nestlé has said it wants to take full ownership of Seres Therapeutics’ Vowst microbiome therapy for Clostridiodes difficile infections (CDI), upgrading its current co-marketing ...
announced today the receipt of a $50 million installment payment related to the Company's previously announced sale of its VOWST business to Société des Produits Nestlé S.A (SPN, and with ...
Seres led the successful development and approval of VOWST™, the first FDA-approved orally administered microbiome therapeutic, which was sold to Nestlé Health Science in September 2024.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback